Assessment of pharmacokinetics, bioavailability and protein binding of anacetrapib in rats by a simple high-performance liquid chromatography-tandem mass spectrometry method

Author:

Kim Sang-Bum1,Kim Ki Taek2,Joo Jeongmin1,Seo Kyung-Ah1,Hwang Hayoung1,Kim Soong-Hyun1,Song Minsoo1,Lee Sungwoo1,Jahn Alexander3,Cho Hyun-Jong4,Kim Dae-Duk2,Yoon In-Soo5

Affiliation:

1. New Drug Development Center; Daegu-Gyeongbuk Medical Innovation Foundation; Daegu 41061 Republic of Korea

2. College of Pharmacy and Research Institute of Pharmaceutical Sciences; Seoul National University; Seoul 08826 Republic of Korea

3. Department of Biotechnology; Dongseo University; Busan 47011 Republic of Korea

4. College of Pharmacy; Kangwon National University; Gangwon 24341 Republic of Korea

5. College of Pharmacy and Natural Medicine Research Institute; Mokpo National University; Jeonnam 58554 Republic of Korea

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference21 articles.

1. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients;Bloomfield;American Heart Journal,2009

2. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry. Journal of Chromatography B: Analytical Technology in Biomedicine and;Chavez-Eng;Life Sciences,2016

3. Plasma protein binding and pharmacological response;Souich;Clinical Pharmacokinetics,1993

4. Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study;Gotto;Journal of Cardiovascular Pharmacology and Therapeutics,2014

5. Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein;Han;Biochimica Biophysica Acta,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3